English
Nov. 03
2024
In recent years, the global hemodialysis market has continued to expand, mainly driven by the increasing prevalence of chronic kidney disease and the aging trend. According to industry research reports, the global hemodialysis market will exceed US0 billion in 2025, with an average annual growth rate of more than 5%. my country is also paying more attention to chronic diseases. The National Health Commission has proposed a plan for early screening and standardized treatment of patients with chronic kidney disease, further increasing the demand for hemodialysis products. Facing the broad market prospects, domestic medical device manufacturers such as Hebei Ziweishan Pharmaceutical will continue to innovate to meet the personalized needs of different patients and provide support for improving dialysis effects and patients' quality of life. At the same time, challenges faced by the industry, such as dialysis technology innovation and safety control standards, will also prompt companies to increase investment in research and development and improve product technology.
Related news
Nov. 04, 2024
With the popularity of hemodialysis treatment, the selection of hemodialysis concentrate has gradually become a focus of attention for patients and medical institutions. Choosing the appropriate dialysis concentrate can not only effectively remove metabolic waste, but also reduce the risk of adverse reactions.
Hemodialysis market demand continues to grow, and the industry has broad prospects for development
Nov. 03, 2024
In recent years, the global hemodialysis market has continued to expand, mainly driven by the increasing prevalence of chronic kidney disease and the aging trend.
Oct. 08, 2024
In February 2024, Hebei Ziweishan Pharmaceutical Co., Ltd. was rated as an "Excellent Private Enterprise" by the Baoding Municipal Party Committee and Municipal Government. This is a sign of the company's success in hemodialysis Highly recognized for contributions to the product and medical device fields.
Composed of pure cotton non-woven fabric, double long-chain quaternary ammonium salts and purified water. The active ingredient is didecyldimethylammonium chloride, with a content of 0.28-0.32%.
Hemodialysis Concentrate/Substance
Hebei Ziweishan Pharmaceutical provides a variety of formulas of hemodialysis concentrates, including high-calcium, low-calcium, high-potassium, and sugar-containing formulas, which meet ultra-pure dialysate standards and are suitable for a variety of dialysis machine models to meet the individual needs of different patients. Safe and stable, welco
Hemodialysis Powder Concentrate
Hebei Ziweishan Pharmaceutical provides high-purity hemodialysis concentrated powder, which complies with GMP standards, has few impurities, high safety, low acetate content, and is suitable for long-term dialysis and concentration For liquid use. To meet the efficient and safe dialysis needs of medical institutions across the country, consultation
